Medindia
Medindia LOGIN REGISTER
Advertisement

Cipher Pharmaceuticals Reports First Quarter 2019 Financial Results

Friday, May 10, 2019 General News
Advertisement

 (IN THOUSANDS OF U.S. DOLLARS) 

Three months endedMarch 31, 2019

Three months endedMarch 31, 2018

$

$

Income (loss) from continuing operations

816

(951)

Add back:

Depreciation and amortization

299

226

Interest expense, net

222

130

Income taxes

423

(141)

EBITDA

1,760

(736)

Change in fair value of derivative financial instrument

(12)

(321)

Loss (gain) from the translation of Canadian cash balances

(26)

41

Impairment of intangible assets



1,832

Share-based compensation

32

156

Adjusted EBITDA

1,754

972

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close